Cited by 102Growth Hormone and Insulin-like Growth FactorsHypothalamic control of reproductive hormonesPituitary Gland Disorders and Treatments

Gender differences in secretory activity of the human somatotropic (growth hormone) axis

Veldhuis, Johannes D·1996·European Journal of Endocrinology

Abstract

Major gender differences exist in the prevalence and severity of various disease states, rates of organ-specific aging and drug and hormone metabolism. Increased understanding of the mechanistic bases for these important sex differences is likely to stimulate new prognostic, therapeutic and diagnostic insights over many succeeding decades. I will outline clinical data that bear on regulatory mechanisms that give rise to sex-based differences in the neuroendocrine activity of the human somatotropic (GH) axis. Such studies have important implications in both pubertal and gonadoprival states, such as aging and the menopause, when the sex-steroid milieu changes dramatically.

Integrity signals

Registry

Crossref · 10.1530/eje.0.1340287

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endogenous GH secretion in young women is consistently higher (typically twice as high) as in young men of similar age.

    “The proposal that the sex difference in muscle mass and function might be due to sex differences in endogenous GH secretion (116) is refuted by the extensive and conclusive clinical evidence that endogenous GH secretion in young women is consistently higher (typically twice as high) as in young men of similar age (163–170).”

Cited by

Sorted by citations

Authors
Veldhuis, J. D.
Affiliations
University of Virginia (US)
Corresponding author
Veldhuis, Johannes D
Venue
European Journal of Endocrinology
Published
1996-03
Volume
134
Issue
3
Pages
287-295
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2136396730
Cited by
102
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 3 · 2018: 1 · 2016: 1 · 2015: 1 · 2013: 4 · 2012: 1
FWCI
6.69
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • California HIV/AIDS Research Program
  • National Institutes of Health (5k04hd000634-02, 5p30dk038942-05)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 38942)
  • National Center for Research Resources (RR 00847, M01RR000847)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (1-K04-HD-00634)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
sex differences, growth hormone, somatotropic axis, neuroendocrine regulation, puberty, gonadectomy, aging, menopause, sex steroids, hormone secretion
MeSH terms
Female, Humans, Kinetics, Male, Menstrual Cycle, Neurosecretory Systems, Pulsatile Flow, Sex Characteristics, Growth Hormone, Growth Hormone-Releasing Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review